Designing Anti-Cytokine Trispecific Antibodies: Strategies for Efficacy, Developability & Clinical Success

  • Navigating design considerations when adding third and fourth targets while maintaining structural integrity and functionality
  • Balancing potency, safety, and pharmacokinetics in increasingly complex multispecific molecules
  • Establishing developable and well-behaved multi-specific molecules